Can experts tell real from fake ANA cell images?
Part of Immune system & allergy clinical trials.
This study tests how well lab professionals can tell apart real and computer-generated images of cells used in ANA testing. Your experience will help improve the technology.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You work at a trusted medical institution.
- You have a relevant professional certificate or qualification.
- You have at least one year of experience reading ANA test patterns in a lab.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well artificial intelligence (AI) helps pathologists make diagnoses from digital tissue images. It may lead to faster and more accurate results for patients like you.
This study uses artificial intelligence (AI) to look at ultrasound images and cell samples from thyroid nodules that had an unclear biopsy result. The goal is to see if AI can better tell which nodules are cancerous, helping avoid unnecessary surgery in the future.
This study uses artificial intelligence to analyze PET/CT scans of people with T-NK cell lymphoma. The goal is to see if the AI can help doctors better diagnose this rare cancer, predict how well treatment will work, and forecast long-term outcomes.
This study tests how well an AI system can diagnose retinal diseases from eye photos. It might help if you need a quick and accurate diagnosis using standard eye imaging.
This trial tests whether an AI tool helps pathologists read your tissue samples more accurately. It's a study for people who have had a stomach biopsy or gastric cancer surgery, where digital images of the tissue are available.
This trial uses artificial intelligence to help doctors assess bone age in children from a single X-ray. It compares AI results with radiologists' readings.
Hear when a new Artifical Intelligence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.